Charles McDermott's most recent trade in Equillium Inc was a trade of 20,000 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Equillium Inc | Charles McDermott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 20,000 | 20,000 | - | - | Director Stock Option (right to buy) | |
| Equillium Inc | Charles McDermott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Equillium Inc | Charles McDermott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Equillium Inc | Charles McDermott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Equillium Inc | Charles McDermott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 20,770 | 20,770 | - | - | Stock Option (right to buy) |